You are here:

We are pleased to announce the acquisition of ID bio by the French group Novacap, worldwide player in the chemical and pharmaceutical industry.

“Novacap will support ID bio to accelerate its development leveraging the two companies' market approaches and recognised expertise. The complementarities between our two groups open up outstanding prospects for the future”, said Jean Pierre Picot, Founding President of ID bio.

Complete press release available here.